← 產業報告目錄
Ovarian Cancer Market Size, Share & Trends Analysis Report By Treatment (Chemotherapy, Hormonal Therapy, Targeted Therapy, and Surgery), Region And Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-04頁數 180報告編號 INSIGHTACE-a3bf9d37b8
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
A CAGR of 10.5% is forecasted for the global Ovarian Cancer Market over the assessment period of 2024 through 2031.
The Ovarian Cancer sector involves dynamics.
The market's upward path is bolstered by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Ovarian Cancer Market Snapshot
Chapter 4. Global Ovarian Cancer Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Treatment Estimates & Trend Analysis
5.1. By Treatment & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Treatment:
5.2.1. Chemotherapy
5.2.2. Targeted Therapy
5.2.3. Hormonal Therapy
5.2.4. Surgery
Chapter 6. Ovarian Cancer Market Segmentation 2: Regional Estimates & Trend Analysis
6.1. North America
6.1.1. North America Ovarian Cancer Market revenue (US$ Million) estimates and forecasts By Treatment, 2024 - 2031
6.1.2. North America Ovarian Cancer Market revenue (US$ Million) estimates and forecasts by country, 2024 - 2031
6.2. Europe
6.2.1. Europe Ovarian Cancer Market revenue (US$ Million) By Treatment, 2024 - 2031
6.2.2. Europe Ovarian Cancer Market revenue (US$ Million) by country, 2024 - 2031
6.3. Asia Pacific
6.3.1. Asia Pacific Ovarian Cancer Market revenue (US$ Million) By Treatment, 2024 - 2031
6.3.2. Asia Pacific Ovarian Cancer Market revenue (US$ Million) by country, 2024 - 2031
6.4. Latin America
6.4.1. Latin America Ovarian Cancer Market revenue (US$ Million) By Treatment, 2024 - 2031
6.4.2. Latin America Ovarian Cancer Market revenue (US$ Million) by country, 2024 - 2031
6.5. Middle East & Africa
6.5.1. Middle East & Africa Ovarian Cancer Market revenue (US$ Million) By Treatment, 2024 - 2031
6.5.2. Middle East & Africa Ovarian Cancer Market revenue (US$ Million) by country, 2024 - 2031
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. Pfizer Inc
7.2.2. Fresenius Kabi USA, LLC
7.2.3. Teva Pharmaceuticals USA, Inc
7.2.4. F. Hoffmann-La Roche AG
7.2.5. AstraZeneca
7.2.6. Tesaro Inc
7.2.7. Clovis Oncology, Inc.
7.2.8. Other Key Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們